stocks logo

GEHC

GE Healthcare Technologies Inc
$
72.520
-5.2(-6.691%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
73.490
Open
73.225
VWAP
--
Vol
1.34M
Mkt Cap
35.59B
Low
70.7462
Amount
--
EV/EBITDA(TTM)
12.00
Total Shares
456.47M
EV
42.16B
EV/OCF(TTM)
23.61
P/S(TTM)
1.80
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
5.54B
+4.1%
1.167
-19.51%
5.03B
+3.37%
0.945
-17.12%
4.97B
+2.6%
0.924
-7.59%
Estimates Revision
The market is revising Upward the revenue expectations for GE HealthCare Technologies Inc. (GEHC) for FY2025, with the revenue forecasts being adjusted by 1.2% over the past three months. During the same period, the stock price has changed by 4.11%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.2%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-13.74%
In Past 3 Month
Stock Price
Go Up
up Image
+4.11%
In Past 3 Month
12 Analyst Rating
up Image
16.52% Upside
Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 84.50 USD with a low forecast of 73.00 USD and a high forecast of 95.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
4 Hold
0 Sell
Moderate Buy
up Image
16.52% Upside
Current: 72.520
sliders
Low
73.00
Averages
84.50
High
95.00
BTIG
Buy
maintain
$82 -> $87
2025-07-14
Reason
BTIG raised the firm's price target on GE HealthCare to $87 from $82 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results in MedTech. Healthcare was a laggard in Q2 relative to the S&P, and early into Q3, MedTech is underperforming as fears of Medicaid cuts and hospital closures weigh on the sector following recent legislation, the analyst tells investors in a research note. The fears are likely overblown, though the earnings season is likely to offer a mixed picture as sentiment is extremely binary right now, with some companies pushing extreme valuations and others "left for dead", BTIG notes. The firm adds however that on one hand, inflation is calm, markets are at highs, and Fx has turned demonstrably favorable.
Citi
Buy
maintain
$86 -> $89
2025-07-09
Reason
Citi raised the firm's price target on GE HealthCare to $89 from $86 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Goldman Sachs
David Roman
Hold
to
Strong Buy
Upgrades
$85 → $100
2025-03-11
Reason
Wells Fargo
Larry Biegelsen
Buy
Maintains
$96 → $103
2025-02-14
Reason
Citigroup
Joanne Wuensch
Strong Buy
Maintains
$103 → $110
2025-02-13
Reason
Jefferies
Matthew Taylor
Hold
to
Strong Buy
Upgrades
$95 → $103
2025-01-08
Reason
Jefferies upgraded GE HealthCare to Buy from Hold with a price target of $103, up from $95. The stock has pulled back and now trades at "just" 17-18 times estimated 2025 earnings, below GE HealthCare average, peers, and well off recent highs of 20 times, the analyst tells investors in a research note. The firm says the push out of China stimulus "has helped re-base expects, creating an entry point." GE is poised to gain share in healthy markets, contends Jefferies.

Valuation Metrics

The current forward P/E ratio for GE Healthcare Technologies Inc (GEHC.O) is 19.52, compared to its 5-year average forward P/E of 18.58. For a more detailed relative valuation and DCF analysis to assess GE Healthcare Technologies Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
18.58
Current PE
19.52
Overvalued PE
20.25
Undervalued PE
16.91

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
11.51
Current EV/EBITDA
12.61
Overvalued EV/EBITDA
13.18
Undervalued EV/EBITDA
9.83

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
1.76
Current PS
1.73
Overvalued PS
2.03
Undervalued PS
1.48

Financials

Annual
Quarterly
FY2025Q1
YoY :
+2.73%
4.78B
Total Revenue
FY2025Q1
YoY :
-11.97%
581.00M
Operating Profit
FY2025Q1
YoY :
+51.55%
588.00M
Net Income after Tax
FY2025Q1
YoY :
+51.85%
1.23
EPS - Diluted
FY2025Q1
YoY :
-64.23%
98.00M
Free Cash Flow
FY2025Q1
YoY :
+3.03%
42.12
Gross Profit Margin - %
FY2025Q1
YoY :
-18.41%
6.96
FCF Margin - %
FY2025Q1
YoY :
+47.60%
12.31
Net Margin - %
FY2025Q1
YoY :
+29.18%
14.74
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
309.3K
USD
1
0-12
Months
1.6M
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 129.92% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
2.7M
Volume
7
6-9
Months
1.2M
Volume
5
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
7
1.7M
Volume
Months
6-9
12
3.7M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
16.0K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
2
16.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
8.0K
USD
Months
0-12
0
0.0
USD
Months

GEHC News & Events

Events Timeline

2025-07-30 (ET)
2025-07-30
06:22:48
GE HealthCare raises FY25 adjusted EPS view to $4.43-$4.63 from $3.90-$4.10
select
2025-07-30
06:20:28
GE HealthCare reports Q2 adjusted EPS $1.06, consensus 92c
select
2025-07-29 (ET)
2025-07-29
20:25:00
Notable companies reporting before tomorrow's open
select
Sign Up For More Events

News

9.5
10:20 AMNewsfilter
PinnedGE HealthCare reports second quarter 2025 financial results
9.5
06:23 AMSeekingAlpha
PinnedGE HealthCare Technologies Non-GAAP EPS of $1.06 beats by $0.14, revenue of $5B beats by $30M
7.0
10:53 AMWSJ
GE HealthCare Raises 2025 Outlook After Earlier Reduction
Sign Up For More News

FAQ

arrow icon

What is GE Healthcare Technologies Inc (GEHC) stock price today?

The current price of GEHC is 72.52 USD — it has decreased -6.69 % in the last trading day.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s business?

arrow icon

What is the price predicton of GEHC Stock?

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s revenue for the last quarter?

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for GE Healthcare Technologies Inc (GEHC)'s fundamentals?

arrow icon

How many employees does GE Healthcare Technologies Inc (GEHC). have?

arrow icon

What is GE Healthcare Technologies Inc (GEHC) market cap?